Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Operating Officer
-
Stock Symbol
-
MNPR on Nasdaq
Andrew Cittadine - trading volume in the past year for Monopar Therapeutics
Holdings reported by Andrew Cittadine for Monopar Therapeutics
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
42K |
$1.53M |
$36.41 |
Mar 31, 2025 |
Direct |
|
|
| Restricted Stock Units |
51.7K |
$1.14M |
$22.00 |
Mar 4, 2025 |
Direct |
Common Stock |
|
| Stock Options |
43.4K |
|
|
Mar 4, 2025 |
Direct |
Common Stock |
|
| Stock Options |
25K |
|
|
May 22, 2024 |
Direct |
Common Stock |
|
Transactions reported by Andrew Cittadine for Monopar Therapeutics
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.